Although CBR-5884 reportedly has no effect on cell lines that lack PHGDH expression at concentrations of 30 μM in vitro [28], it reduced the proliferation of neuroblastoma cells in a dose-dependent manner. Here, PHGDH is linked to neuroblastoma.